SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-249887
Filing Date
2017-08-07
Accepted
2017-08-07 16:13:00
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d365030d10q.htm 10-Q 656283
2 EX-31.1 d365030dex311.htm EX-31.1 9017
3 EX-31.2 d365030dex312.htm EX-31.2 8890
4 EX-32.1 d365030dex321.htm EX-32.1 5320
  Complete submission text file 0001193125-17-249887.txt   2852527

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gbt-20170630.xml EX-101.INS 484236
6 XBRL TAXONOMY EXTENSION SCHEMA gbt-20170630.xsd EX-101.SCH 30397
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20170630_cal.xml EX-101.CAL 50444
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20170630_def.xml EX-101.DEF 92515
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20170630_lab.xml EX-101.LAB 272711
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20170630_pre.xml EX-101.PRE 189236
Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 171011635
SIC: 2834 Pharmaceutical Preparations